Fatal Adverse Events of Dabigatran Combined With Aspirin in Elderly Patients: An Analysis Using Data From VigiBase

Introduction: The elderly are vulnerable to cardiovascular diseases and the incidence of atrial fibrillation (AF) and venous thromboembolism (VTE) increases significantly with age. Dabigatran is a commonly used new oral anticoagulant approved by the FDA for stroke prevention in patients with non-val...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qingxia, Ding, Qian, Yan, Suying, Yue, Qun-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727914/
https://www.ncbi.nlm.nih.gov/pubmed/35002709
http://dx.doi.org/10.3389/fphar.2021.769251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727914/
https://www.ncbi.nlm.nih.gov/pubmed/35002709
http://dx.doi.org/10.3389/fphar.2021.769251

Ejemplares similares